A Convenient Cell Culture Model for CML Acquired Resistance Through BCR-ABL Mutations.
Wang, Zhiqiang
A Convenient Cell Culture Model for CML Acquired Resistance Through BCR-ABL Mutations. [electronic resource] - Methods in molecular biology (Clifton, N.J.) 2016 - 149-57 p. digital
Publication Type: Journal Article
1940-6029
10.1007/978-1-4939-4011-0_13 doi
Apoptosis
Blast Crisis--pathology
Cell Line, Tumor
Dasatinib--pharmacology
Drug Resistance, Neoplasm
Fusion Proteins, bcr-abl--genetics
Humans
Imatinib Mesylate--pharmacology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--genetics
Models, Biological
Mutation
Pyrimidines--pharmacology
A Convenient Cell Culture Model for CML Acquired Resistance Through BCR-ABL Mutations. [electronic resource] - Methods in molecular biology (Clifton, N.J.) 2016 - 149-57 p. digital
Publication Type: Journal Article
1940-6029
10.1007/978-1-4939-4011-0_13 doi
Apoptosis
Blast Crisis--pathology
Cell Line, Tumor
Dasatinib--pharmacology
Drug Resistance, Neoplasm
Fusion Proteins, bcr-abl--genetics
Humans
Imatinib Mesylate--pharmacology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--genetics
Models, Biological
Mutation
Pyrimidines--pharmacology